Know Cancer

or
forgot password

Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT(Positron Emission Tomography/Computed Tomography)


N/A
18 Years
79 Years
Open (Enrolling)
Female
Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

Thank you

Trial Information

Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT(Positron Emission Tomography/Computed Tomography)


Inclusion Criteria:



- Newly diagnosed patients with advanced epithelial ovarian, primary peritoneal cancer
or fallopian tube cancer.

- age 18-79 years

- informed concent

Exclusion Criteria:

- diabetes

- previous cancer

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

PET/CT (positron emission tomography/computed tomography)compared with contrast-enhanced CT in preoperative evaluation of disease burden in patients with advanced Epithelial ovarian cancer (EOC).

Outcome Description:

Patient is scanned with whole body Fdg PET/CT and contrast-enhanced CT in a row within 3 weeks preoperatively. Findings are compared with intraoperative surgical status evaluated by operator and confirmed with biopsies.

Outcome Time Frame:

PET/CT, contrance-enhanced CT and surgical status and histopatholocical findings are compared 1 month after surgery

Safety Issue:

No

Principal Investigator

Seija Grénman, MD, PhD

Investigator Role:

Study Director

Investigator Affiliation:

Turku University hospital, Department of Obstetrics and Gynecology

Authority:

Finland: Ethics Committee

Study ID:

53/180/2009

NCT ID:

NCT01276574

Start Date:

October 2009

Completion Date:

December 2017

Related Keywords:

  • Epithelial Ovarian Cancer
  • Peritoneal Cancer
  • Fallopian Tube Cancer
  • PET/CT
  • Ovarian cancer
  • HE4
  • Ovarian Neoplasms
  • Peritoneal Neoplasms
  • Fallopian Tube Neoplasms
  • Neoplasms, Glandular and Epithelial

Name

Location